来自MSN1 小时
FDA Announcement: The First Generic GLP-1 Shot Has Just Been Approved
This could start to bring down the cost of brand-name competitors—here's who may get to use it, and one major difference from ...
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
MyChesCo on MSN2 天
FDA Approves First Generic Liraglutide Injection, Ushering in a New Era for Type 2 Diabetes ...
The fight against type 2 diabetes just reached a groundbreaking milestone. Last week, the U.S. Food and Drug Administration ...
腾讯网8 天
美国首仿！翰宇药业利拉鲁肽注射液获FDA批准上市
12月25日，翰宇药业发布企业公告消息称，其近日收到美国食品药品监督管理局的通知，由翰宇药业及 Hikma Pharmaceuticals USA, Inc.联合向 FDA ...
Drug Store News7 小时
Hikma gets FDA nod for generic Victoza, launches 2 new generics
Generic Victoza is a GLP-1 receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 ...
Pharmaceutical Technology3 天
Liraglutide by Novo Nordisk for Alzheimer’s Disease: Likelihood of Approval
Liraglutide is under development for the treatment of obesity, ileal pouch-anal anastomosis and Alzheimer's disease. It was also under development for non-alcoholic steatohepatitis, psoriatic ...
腾讯网9 天
翰宇药业(300199.SZ)：利拉鲁肽注射液获得美国FDA批准证书
格隆汇12月24日丨翰宇药业(300199.SZ)公布，2024年12月23日，深圳翰宇药业股份有限公司收到美国食品药品监督管理局(简称“FDA”)的通知，由翰宇药业及Hikma Pharmaceuticals USA, ...
Pharmaceutical Technology3 天
Liraglutide by Novo Nordisk for Obesity: Likelihood of Approval
Liraglutide is under development for the treatment of obesity, ileal pouch-anal anastomosis and Alzheimer's disease. It was also under development for non-alcoholic steatohepatitis, psoriatic ...
McKnight's Long-Term Care News3 天
FDA approves first generic liraglutide once-daily injection
The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), ...
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
MedPage Today10 天
First Generic of Once-Daily GLP-1 Injection Approved for Diabetes
The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...
Psychology Today6 天
GLP-1RAs in People With Higher Weight and Eating Disorders
GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...